{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:28:24Z","timestamp":1790803704317,"version":"4.1.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T00:00:00Z","timestamp":1549843200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Genet"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1038\/s41588-018-0339-x","type":"journal-article","created":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T12:04:17Z","timestamp":1549886657000},"page":"560-567","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":154,"title":["Landscape of B cell immunity and related immune evasion in human cancers"],"prefix":"10.1038","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3517-6351","authenticated-orcid":false,"given":"Xihao","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxin","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiwen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binbin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengqing","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyu","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai W.","family":"Wucherpfennig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nir","family":"Hacohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4450-7239","authenticated-orcid":false,"given":"Jun S.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8617-900X","authenticated-orcid":false,"given":"Bo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4736-7339","authenticated-orcid":false,"given":"X. Shirley","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,11]]},"reference":[{"key":"339_CR1","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","volume":"48","author":"V Thorsson","year":"2018","unstructured":"Thorsson, V. et al. The immune landscape of cancer. Immunity 48, 812\u2013830.e14 (2018).","journal-title":"Immunity"},{"key":"339_CR2","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/nri3795","volume":"15","author":"SL Nutt","year":"2015","unstructured":"Nutt, S. L., Hodgkin, P. D., Tarlinton, D. M. & Corcoran, L. M. The generation of antibody-secreting plasma cells. Nat. Rev. Immunol. 15, 160\u2013171 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"339_CR3","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1084\/jem.183.3.1161","volume":"183","author":"G Raposo","year":"1996","unstructured":"Raposo, G. et al. B lymphocytes secrete antigen-presenting vesicles. J. Exp. Med. 183, 1161\u20131172 (1996).","journal-title":"J. Exp. Med."},{"key":"339_CR4","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/icb.2011.64","volume":"90","author":"M Hagn","year":"2012","unstructured":"Hagn, M. et al. Human B cells differentiate into granzyme B-secreting cytotoxic B lymphocytes upon incomplete T-cell help. Immunol. Cell Biol. 90, 457\u2013467 (2012).","journal-title":"Immunol. Cell Biol."},{"key":"339_CR5","doi-asserted-by":"publisher","first-page":"4977","DOI":"10.4049\/jimmunol.1001323","volume":"185","author":"BH Nelson","year":"2010","unstructured":"Nelson, B. H. CD20+ B cells: the other tumor-infiltrating lymphocytes. J. Immunol. 185, 4977\u20134982 (2010).","journal-title":"J. Immunol."},{"key":"339_CR6","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.4161\/onci.20641","volume":"1","author":"M Linnebacher","year":"2012","unstructured":"Linnebacher, M. & Maletzki, C. Tumor-infiltrating B cells: the ignored players in tumor immunology. Oncoimmunology 1, 1186\u20131188 (2012).","journal-title":"Oncoimmunology"},{"key":"339_CR7","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.4161\/onci.21650","volume":"1","author":"JS Nielsen","year":"2012","unstructured":"Nielsen, J. S. & Nelson, B. H. Tumor-infiltrating B cells and T cells: working together to promote patient survival. Oncoimmunology 1, 1623\u20131625 (2012).","journal-title":"Oncoimmunology"},{"key":"339_CR8","doi-asserted-by":"publisher","first-page":"5220","DOI":"10.1158\/1078-0432.CCR-08-0133","volume":"14","author":"KI Al-Shibli","year":"2008","unstructured":"Al-Shibli, K. I. et al. Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer. Clin. Cancer Res. 14, 5220\u20135227 (2008).","journal-title":"Clin. Cancer Res."},{"key":"339_CR9","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s00262-003-0409-4","volume":"52","author":"JA Coronella-Wood","year":"2003","unstructured":"Coronella-Wood, J. A. & Hersh, E. M. Naturally occurring B-cell responses to breast cancer. Cancer Immunol. Immunother. 52, 715\u2013738 (2003).","journal-title":"Cancer Immunol. Immunother."},{"key":"339_CR10","doi-asserted-by":"publisher","first-page":"e6412","DOI":"10.1371\/journal.pone.0006412","volume":"4","author":"K Milne","year":"2009","unstructured":"Milne, K. et al. Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors. PLoS ONE 4, e6412 (2009).","journal-title":"PLoS ONE"},{"key":"339_CR11","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.cell.2017.01.014","volume":"168","author":"XS Liu","year":"2017","unstructured":"Liu, X. S. & Mardis, E. R. Applications of immunogenomics to cancer. Cell 168, 600\u2013612 (2017).","journal-title":"Cell"},{"key":"339_CR12","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S1074-7613(00)00006-6","volume":"13","author":"JL Xu","year":"2000","unstructured":"Xu, J. L. & Davis, M. M. Diversity in the CDR3 region of V(H) is sufficient for most antibody specificities. Immunity 13, 37\u201345 (2000).","journal-title":"Immunity"},{"key":"339_CR13","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1146\/annurev.immunol.26.021607.090248","volume":"26","author":"J Stavnezer","year":"2008","unstructured":"Stavnezer, J., Guikema, J. E. & Schrader, C. E. Mechanism and regulation of class switch recombination. Annu. Rev. Immunol. 26, 261\u2013292 (2008).","journal-title":"Annu. Rev. Immunol."},{"key":"339_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/gad.1161904","volume":"18","author":"Z Li","year":"2004","unstructured":"Li, Z., Woo, C. J., Iglesias-Ussel, M. D., Ronai, D. & Scharff, M. D. The generation of antibody diversity through somatic hypermutation and class switch recombination. Genes Dev. 18, 1\u201311 (2004).","journal-title":"Genes Dev."},{"key":"339_CR15","doi-asserted-by":"publisher","first-page":"E862","DOI":"10.1073\/pnas.1417683112","volume":"112","author":"D Gadala-Maria","year":"2015","unstructured":"Gadala-Maria, D., Yaari, G., Uduman, M. & Kleinstein, S. H. Automated analysis of high-throughput B-cell sequencing data reveals a high frequency of novel immunoglobulin V gene segment alleles. Proc. Natl Acad. Sci. USA 112, E862\u2013E870 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"339_CR16","doi-asserted-by":"publisher","first-page":"7846","DOI":"10.1073\/pnas.1608649113","volume":"113","author":"SG Lin","year":"2016","unstructured":"Lin, S. G. et al. Highly sensitive and unbiased approach for elucidating antibody repertoires. Proc. Natl Acad. Sci. USA 113, 7846\u20137851 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"339_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-015-0243-2","volume":"7","author":"G Yaari","year":"2015","unstructured":"Yaari, G. & Kleinstein, S. H. Practical guidelines for B-cell receptor repertoire sequencing analysis. Genome Med. 7, 121 (2015).","journal-title":"Genome Med."},{"key":"339_CR18","doi-asserted-by":"publisher","first-page":"4322","DOI":"10.1073\/pnas.1503587112","volume":"112","author":"JS Blachly","year":"2015","unstructured":"Blachly, J. S. et al. Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in chronic lymphocytic leukemia. Proc. Natl Acad. Sci. USA 112, 4322\u20134327 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"339_CR19","doi-asserted-by":"publisher","first-page":"3729","DOI":"10.1093\/bioinformatics\/btw526","volume":"32","author":"LE Mose","year":"2016","unstructured":"Mose, L. E. et al. Assembly-based inference of B-cell receptor repertoires from short read RNA sequencing data with V\u2019DJer. Bioinformatics 32, 3729\u20133734 (2016).","journal-title":"Bioinformatics"},{"key":"339_CR20","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/gene.2016.45","volume":"18","author":"S Liu","year":"2017","unstructured":"Liu, S. et al. Direct measurement of B-cell receptor repertoire\u2019s composition and variation in systemic lupus erythematosus. Genes Immun. 18, 22\u201327 (2017).","journal-title":"Genes Immun."},{"key":"339_CR21","doi-asserted-by":"publisher","first-page":"3679","DOI":"10.1182\/blood-2015-03-635169","volume":"125","author":"DM Kurtz","year":"2015","unstructured":"Kurtz, D. M. et al. Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing. Blood 125, 3679\u20133687 (2015).","journal-title":"Blood"},{"key":"339_CR22","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.celrep.2017.07.016","volume":"20","author":"H Katoh","year":"2017","unstructured":"Katoh, H. et al. Immunogenetic profiling for gastric cancers identifies sulfated glycosaminoglycans as major and functional B cell antigens in human malignancies. Cell Rep. 20, 1073\u20131087 (2017).","journal-title":"Cell Rep."},{"key":"339_CR23","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/ng.3581","volume":"48","author":"B Li","year":"2016","unstructured":"Li, B. et al. Landscape of tumor-infiltrating T cell repertoire of human cancers. Nat. Genet. 48, 725\u2013732 (2016).","journal-title":"Nat. Genet."},{"key":"339_CR24","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/ng.3820","volume":"49","author":"B Li","year":"2017","unstructured":"Li, B. et al. Ultrasensitive detection of TCR hypervariable region in solid-tissue RNA-seq data. Nat. Genet. 49, 482\u2013483 (2017).","journal-title":"Nat. Genet."},{"key":"339_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4682-11-30","volume":"11","author":"B Shi","year":"2014","unstructured":"Shi, B. et al. Comparative analysis of human and mouse immunoglobulin variable heavy regions from IMGT\/LIGM-DB with IMGT\/HighV-QUEST. Theor. Biol. Med. Model. 11, 30 (2014).","journal-title":"Theor. Biol. Med. Model."},{"key":"339_CR26","doi-asserted-by":"publisher","first-page":"D413","DOI":"10.1093\/nar\/gku1056","volume":"43","author":"MP Lefranc","year":"2015","unstructured":"Lefranc, M. P. et al. IMGT(R), the international ImMunoGeneTics information system(R) 25 years on. Nucleic Acids Res. 43, D413\u2013D422 (2015).","journal-title":"Nucleic Acids Res."},{"key":"339_CR27","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1016\/j.jaci.2009.09.046","volume":"125","author":"HW Schroeder Jr","year":"2010","unstructured":"Schroeder, H. W. Jr & Cavacini, L. Structure and function of immunoglobulins. J. Allergy Clin. Immunol. 125, S41\u2013S52 (2010).","journal-title":"J. Allergy Clin. Immunol."},{"key":"339_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev.biochem.76.061705.090740","volume":"76","author":"JM Noia Di","year":"2007","unstructured":"Di Noia, J. M. & Neuberger, M. S. Molecular mechanisms of antibody somatic hypermutation. Annu. Rev. Biochem. 76, 1\u201322 (2007).","journal-title":"Annu. Rev. Biochem."},{"key":"339_CR29","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0167-4781(92)90134-L","volume":"1171","author":"IB Rogozin","year":"1992","unstructured":"Rogozin, I. B. & Kolchanov, N. A. Somatic hypermutagenesis in immunoglobulin genes. II. Influence of neighbouring base sequences on mutagenesis. Biochim. Biophys. Acta 1171, 11\u201318 (1992).","journal-title":"Biochim. Biophys. Acta"},{"key":"339_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/gad.200014.112","volume":"27","author":"C Keim","year":"2013","unstructured":"Keim, C., Kazadi, D., Rothschild, G. & Basu, U. Regulation of AID, the B-cell genome mutator. Genes Dev. 27, 1\u201317 (2013).","journal-title":"Genes Dev."},{"key":"339_CR31","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.immuni.2016.06.014","volume":"45","author":"AT Krishnamurty","year":"2016","unstructured":"Krishnamurty, A. T. et al. Somatically hypermutated Plasmodium-specific IgM(+) memory B cells are rapid, plastic, early responders upon malaria rechallenge. Immunity 45, 402\u2013414 (2016).","journal-title":"Immunity"},{"key":"339_CR32","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3389\/fimmu.2017.00389","volume":"8","author":"K Kitaura","year":"2017","unstructured":"Kitaura, K. et al. Different somatic hypermutation levels among antibody subclasses disclosed by a new next-generation sequencing-based antibody repertoire analysis. Front. Immunol. 8, 389 (2017).","journal-title":"Front. Immunol."},{"key":"339_CR33","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nri1896","volume":"6","author":"VH Odegard","year":"2006","unstructured":"Odegard, V. H. & Schatz, D. G. Targeting of somatic hypermutation. Nat. Rev. Immunol. 6, 573\u2013583 (2006).","journal-title":"Nat. Rev. Immunol."},{"key":"339_CR34","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1182\/blood-2008-02-078071","volume":"112","author":"TW LeBien","year":"2008","unstructured":"LeBien, T. W. & Tedder, T. F. B lymphocytes: how they develop and function. Blood 112, 1570\u20131580 (2008).","journal-title":"Blood"},{"key":"339_CR35","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/icb.2014.44","volume":"92","author":"KJ Jackson","year":"2014","unstructured":"Jackson, K. J., Wang, Y. & Collins, A. M. Human immunoglobulin classes and subclasses show variability in VDJ gene mutation levels. Immunol. Cell Biol. 92, 729\u2013733 (2014).","journal-title":"Immunol. Cell Biol."},{"key":"339_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-1028-7","volume":"17","author":"B Li","year":"2016","unstructured":"Li, B. et al. Comprehensive analyses of tumor immunity: implications for cancer immunotherapy. Genome Biol. 17, 174 (2016).","journal-title":"Genome Biol."},{"key":"339_CR37","doi-asserted-by":"publisher","first-page":"e985082","DOI":"10.4161\/2162402X.2014.985082","volume":"4","author":"K Geissler","year":"2015","unstructured":"Geissler, K. et al. Immune signature of tumor infiltrating immune cells in renal cancer. Oncoimmunology 4, e985082 (2015).","journal-title":"Oncoimmunology"},{"key":"339_CR38","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1126\/science.1073924","volume":"297","author":"J William","year":"2002","unstructured":"William, J., Euler, C., Christensen, S. & Shlomchik, M. J. Evolution of autoantibody responses via somatic hypermutation outside of germinal centers. Science 297, 2066\u20132070 (2002).","journal-title":"Science"},{"key":"339_CR39","first-page":"MDNA3-0037-2014","volume":"3","author":"JK Hwang","year":"2015","unstructured":"Hwang, J. K., Alt, F. W. & Yeap, L. S. Related mechanisms of antibody somatic hypermutation and class switch recombination. Microbiol. Spectr. 3, MDNA3-0037-2014 (2015).","journal-title":"Microbiol. Spectr."},{"key":"339_CR40","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1126\/science.1203486","volume":"331","author":"RD Schreiber","year":"2011","unstructured":"Schreiber, R. D., Old, L. J. & Smyth, M. J. Cancer immunoediting: integrating immunity\u2019s roles in cancer suppression and promotion. Science 331, 1565\u20131570 (2011).","journal-title":"Science"},{"key":"339_CR41","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1038\/nbt.3344","volume":"33","author":"SA Shukla","year":"2015","unstructured":"Shukla, S. A. et al. Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes. Nat. Biotechnol. 33, 1152\u20131158 (2015).","journal-title":"Nat. Biotechnol."},{"key":"339_CR42","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1056\/NEJMoa1604958","volume":"375","author":"JM Zaretsky","year":"2016","unstructured":"Zaretsky, J. M. et al. Mutations associated with acquired resistance to PD-1 blockade in melanoma. N. Engl. J. Med. 375, 819\u2013829 (2016).","journal-title":"N. Engl. J. Med."},{"key":"339_CR43","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s10555-005-6192-2","volume":"24","author":"A Iannello","year":"2005","unstructured":"Iannello, A. & Ahmad, A. Role of antibody-dependent cell-mediated cytotoxicity in the efficacy of therapeutic anti-cancer monoclonal antibodies. Cancer Metastasis Rev. 24, 487\u2013499 (2005).","journal-title":"Cancer Metastasis Rev."},{"key":"339_CR44","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/nri2206","volume":"8","author":"F Nimmerjahn","year":"2008","unstructured":"Nimmerjahn, F. & Ravetch, J. V. Fcgamma receptors as regulators of immune responses. Nat. Rev. Immunol. 8, 34\u201347 (2008).","journal-title":"Nat. Rev. Immunol."},{"key":"339_CR45","doi-asserted-by":"publisher","first-page":"5932","DOI":"10.1038\/onc.2008.267","volume":"27","author":"I Waldhauer","year":"2008","unstructured":"Waldhauer, I. & Steinle, A. NK cells and cancer immunosurveillance. Oncogene 27, 5932\u20135943 (2008).","journal-title":"Oncogene"},{"key":"339_CR46","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.molimm.2004.07.034","volume":"42","author":"MJ Smyth","year":"2005","unstructured":"Smyth, M. J. et al. Activation of NK cell cytotoxicity. Mol. Immunol. 42, 501\u2013510 (2005).","journal-title":"Mol. Immunol."},{"key":"339_CR47","doi-asserted-by":"publisher","first-page":"3716","DOI":"10.1182\/blood-2008-09-179754","volume":"113","author":"P Bruhns","year":"2009","unstructured":"Bruhns, P. et al. Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses. Blood 113, 3716\u20133725 (2009).","journal-title":"Blood"},{"key":"339_CR48","doi-asserted-by":"publisher","first-page":"6368","DOI":"10.1158\/0008-5472.CAN-07-6768","volume":"68","author":"I Waldhauer","year":"2008","unstructured":"Waldhauer, I. et al. Tumor-associated MICA is shed by ADAM proteases. Cancer Res. 68, 6368\u20136376 (2008).","journal-title":"Cancer Res."},{"key":"339_CR49","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/nri1199","volume":"3","author":"DH Raulet","year":"2003","unstructured":"Raulet, D. H. Roles of the NKG2D immunoreceptor and its ligands. Nat. Rev. Immunol. 3, 781\u2013790 (2003).","journal-title":"Nat. Rev. Immunol."},{"key":"339_CR50","doi-asserted-by":"publisher","first-page":"6891","DOI":"10.4049\/jimmunol.171.12.6891","volume":"171","author":"ES Doubrovina","year":"2003","unstructured":"Doubrovina, E. S. et al. Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma. J. Immunol. 171, 6891\u20136899 (2003).","journal-title":"J. Immunol."},{"key":"339_CR51","doi-asserted-by":"publisher","first-page":"3346","DOI":"10.4049\/jimmunol.0903789","volume":"184","author":"G Liu","year":"2010","unstructured":"Liu, G., Atteridge, C. L., Wang, X., Lundgren, A. D. & Wu, J. D. The membrane type matrix metalloproteinase MMP14 mediates constitutive shedding of MHC class I chain-related molecule A independent of A disintegrin and metalloproteinases. J. Immunol. 184, 3346\u20133350 (2010).","journal-title":"J. Immunol."},{"key":"339_CR52","first-page":"97","volume":"6","author":"J Zhang","year":"2015","unstructured":"Zhang, J., Basher, F. & Wu, J. D. NKG2D ligands in tumor immunity: two sides of a coin. Front. Immunol. 6, 97 (2015).","journal-title":"Front. Immunol."},{"key":"339_CR53","doi-asserted-by":"publisher","first-page":"9190","DOI":"10.1073\/pnas.0603503103","volume":"103","author":"M Jinushi","year":"2006","unstructured":"Jinushi, M., Hodi, F. S. & Dranoff, G. Therapy-induced antibodies to MHC class I chain-related protein A antagonize immune suppression and stimulate antitumor cytotoxicity. Proc. Natl Acad. Sci. USA 103, 9190\u20139195 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"339_CR54","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s10549-016-3801-4","volume":"157","author":"Y Tabuchi","year":"2016","unstructured":"Tabuchi, Y. et al. Protective effect of naturally occurring anti-HER2 autoantibodies on breast cancer. Breast Cancer Res. Treat. 157, 55\u201363 (2016).","journal-title":"Breast Cancer Res. Treat."},{"key":"339_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2013-14-4-r36","volume":"14","author":"D Kim","year":"2013","unstructured":"Kim, D. et al. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol. 14, R36 (2013).","journal-title":"Genome Biol."},{"key":"339_CR56","doi-asserted-by":"publisher","first-page":"e178","DOI":"10.1093\/nar\/gkq622","volume":"38","author":"K Wang","year":"2010","unstructured":"Wang, K. et al. MapSplice: accurate mapping of RNA-seq reads for splice junction discovery. Nucleic Acids Res. 38, e178 (2010).","journal-title":"Nucleic Acids Res."},{"key":"339_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2011-12-4-r41","volume":"12","author":"CH Mermel","year":"2011","unstructured":"Mermel, C. H. et al. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 12, R41 (2011).","journal-title":"Genome Biol."},{"key":"339_CR58","doi-asserted-by":"publisher","first-page":"e0160853","DOI":"10.1371\/journal.pone.0160853","volume":"11","author":"WS DeWitt","year":"2016","unstructured":"DeWitt, W. S. et al. A public database of memory and naive B-cell receptor sequences. PLoS ONE 11, e0160853 (2016).","journal-title":"PLoS ONE"},{"key":"339_CR59","doi-asserted-by":"publisher","first-page":"4673","DOI":"10.1093\/nar\/22.22.4673","volume":"22","author":"JD Thompson","year":"1994","unstructured":"Thompson, J. D., Higgins, D. G. & Gibson, T. J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22, 4673\u20134680 (1994).","journal-title":"Nucleic Acids Res."},{"key":"339_CR60","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1093\/bioinformatics\/btv494","volume":"31","author":"U Bodenhofer","year":"2015","unstructured":"Bodenhofer, U., Bonatesta, E., Horejs-Kainrath, C. & Hochreiter, S. msa: an R package for multiple sequence alignment. Bioinformatics 31, 3997\u20133999 (2015).","journal-title":"Bioinformatics"},{"key":"339_CR61","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1093\/bioinformatics\/btg412","volume":"20","author":"E Paradis","year":"2004","unstructured":"Paradis, E., Claude, J. & Strimmer, K. APE: analyses of phylogenetics and evolution in R language. Bioinformatics 20, 289\u2013290 (2004).","journal-title":"Bioinformatics"},{"key":"339_CR62","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/ng.3557","volume":"48","author":"J Kim","year":"2016","unstructured":"Kim, J. et al. Somatic ERCC2 mutations are associated with a distinct genomic signature in urothelial tumors. Nat. Genet. 48, 600\u2013606 (2016).","journal-title":"Nat. Genet."},{"key":"339_CR63","unstructured":"R v. 3.5.1 (The R Project for Statistical Computing, 2018)."}],"updated-by":[{"DOI":"10.1038\/s41588-019-0437-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T00:00:00Z","timestamp":1558051200000}}],"container-title":["Nature Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41588-018-0339-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41588-018-0339-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41588-018-0339-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T11:12:27Z","timestamp":1694603547000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41588-018-0339-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,11]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["339"],"URL":"https:\/\/doi.org\/10.1038\/s41588-018-0339-x","relation":{},"ISSN":["1061-4036","1546-1718"],"issn-type":[{"value":"1061-4036","type":"print"},{"value":"1546-1718","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,11]]},"assertion":[{"value":"8 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2019","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"An amendment to this paper has been published and can be accessed via a link at the top of the paper.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"X.S.L. is a cofounder and board member of GV20 Oncotherapy, SAB of 3DMed Care, consultant for Genentech, and stock holder of BMY, TMO, WBA, ABT, ABBV, and JNJ. J.S.L. is a cofounder and board member of Beijing Neoantigen Biotechnology Co. Ltd, and shareholder of BGNE, DVAX, CELG, NKTR, CRSP, and EDIT. K.W.W. serves on the SAB of Nextech, TCR2, and T-scan. He is also a consultant for Novartis. His laboratory has sponsored research agreements with Novartis, BMS, and Astellas. N.H. is a founder and SAB member of Neon Therapeutics and SAB member of IFM Therapeutics.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}